(Q37194997)

18 August 2017

Proinflammatory consequences of transgenic fas ligand expression in the heart (English)

1 reference

18 August 2017

D P Nelson

1

1 reference

18 August 2017

E Setser

2

1 reference

18 August 2017

D G Hall

3

1 reference

18 August 2017

S M Schwartz

4

1 reference

18 August 2017

T Hewitt

5

1 reference

18 August 2017

R Klevitsky

6

1 reference

18 August 2017

H Osinska

7

1 reference

18 August 2017

D Bellgrau

8

1 reference

18 August 2017

R C Duke

9

1 reference

18 August 2017

J Robbins

10

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

Journal of Clinical Investigation

18 August 2017

1 reference

18 August 2017

105

1 reference

18 August 2017

9

1 reference

18 August 2017

1199-1208

1 reference

TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

Gene transfer of Fas ligand induces tumor regression in vivo

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

The Fas counterattack: a molecular mechanism of tumor immune privilege

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

Fas-ligand: privilege and peril

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

Regulation of the proinflammatory effects of Fas ligand (CD95L).

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

The effect of tumor necrosis factor-alpha on cardiac structure and function: a tale of two cytokines

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

Mouse islet cell lysis mediated by interleukin-1-induced Fas.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

Fas ligand gene transfer to renal allografts in rats: effects on allograft survival

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

Transgenic remodeling of the regulatory myosin light chains in the mammalian heart

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=378206

Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis

3 September 2018

1 reference

12 December 2020

Selective inhibition of protein kinase C isozymes by Fas ligation

1 reference

12 December 2020

The role of Fas in autoimmune diabetes

1 reference

12 December 2020

Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153

1 reference

12 December 2020

Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha

1 reference

12 December 2020

Contribution of Fas ligand to T cell-mediated hepatic injury in mice

1 reference

12 December 2020

A role for CD95 ligand in preventing graft rejection

1 reference

12 December 2020

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

12 December 2020

Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice

1 reference

12 December 2020

Myocyte remodeling during the progression to failure in rats with hypertension

1 reference

12 December 2020

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

12 December 2020

Antitumor effect of locally produced CD95 ligand

1 reference

12 December 2020

Immune response and myoblasts that express Fas ligand

1 reference

12 December 2020

Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats

1 reference

12 December 2020

Chemotactic activity of soluble Fas ligand against phagocytes

1 reference

12 December 2020

Prolonged survival of rat liver allografts transfected with Fas ligand-expressing plasmid

1 reference

12 December 2020

Accelerated rejection of Fas ligand-expressing heart grafts

1 reference

12 December 2020

Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes

1 reference

12 December 2020

Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI8212

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

10791994

1 reference